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ABSTRACT
RNA splicing is an essential step in gene expression,
and is often variable, giving rise to multiple alternat-
10 ivelysplicedmRNAandproteinisoformsfromasingle
gene locus. The design of effective databases to sup-
port experimental and computational investigations
of alternative splicing (AS) is a significant challenge.
In an effort to integrate accurate exon and splice site
15 annotation with current knowledge about splicing
regulatory elements and predicted AS events, and
to link information about the splicing of orthologous
genes in different species, we have developed the
HOLLYWOOD system. This database was built upon
20 genomic annotation of splicing patterns of known
genesderivedfromsplicedalignmentofcomplement-
ary DNAs (cDNAs) and expressed sequence tags,
and links features such as splice site sequence and
strength, exonic splicing enhancers and silencers,
25 conserved and non-conserved patterns of splicing,
and cDNA library information for inferred alternative
exons. HOLLYWOOD was implemented as a relational
database and currently contains comprehensive
information for human and mouse. It is accompanied
30 by a web query tool that allows searches for sets
of exons with specific splicing characteristics or
splicing regulatory element composition, or gives
a graphical or sequence-level summary of splicing
patterns for a specific gene. A streamlined graphical
35 representation of gene splicing patterns is provided,
and these patterns can alternatively be layered onto
existing information in the UCSC Genome Browser.
The database is accessible at http://hollywood.
mit.edu.
40 INTRODUCTION
Gene expression is controlled at several levels, and in meta-
zoan genomes, where the majority of protein-coding genes
contain introns, the splicing of precursors to mRNAs (pre-
mRNAs) constitutes a critical step for regulation of gene
45 expression (1–3). RNA splicing occurs in the nucleus and is
catalyzed by a large ribonucleoprotein (RNP) complex known
as the spliceosome, which is composed of several small nuc-
lear RNPs and over one hundred proteins (4). The processing
of pre- mRNAs is often variable, giving rise to multiple altern-
50 atively spliced mRNAs, which may serve to produce distinct
protein isoforms (5–7). Typical mammalian gene loci span
tens of thousands of nucleotides (nt), with an average of
nine exons/eight introns and the coding region typically span-
ning  1500 nt (8–10). In addition to the precise recognition of
55 splice sites among many possible pseudo-sites, the removal of
introns and the production of the correct message, the
spliceosome must also produce tissue- and developmental
stage-speciﬁc mRNA isoforms and integrate RNA splicing
decisions with other stepsin RNA processing, suchas capping,
60 cleavage and polyadenylation (11,12). Correct pre-mRNA
splicing is generally required for cell viability. At least
15% of point mutations that cause genetic defects do so by
altering splice site sequences (13), and the misregulation of
alternative splicing (AS) is associated with a number of human
65 diseases (14–17).
Alternative pre-mRNA splicing is estimated to affect
more than half of actively transcribed human genes (18),
and the systematic identiﬁcation of AS events is important
for the fundamental understanding of the regulation of gene
70 expression in development, differentiation and human disease
(19,20). A number of AS databases have been constructed,
based on either searches of the scientiﬁc literature (21–23) or
automated large-scale comparisons of transcript and genomic
sequences (see below). The latter approach is made possible
75 by the availability of large repositories of complementary
*To whom correspondence should be addressed. Email: holste@mit.edu
Correspondence may also be addressed to Christopher B. Burge. Tel: +1 617 258 5997; Fax: +1 617 452 2936; Email: cburge@mit.edu
  The Author 2006. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
D56–D62 Nucleic Acids Research, 2006, Vol. 34, Database issue
doi:10.1093/nar/gkj048DNA (cDNA) sequences and expressed sequence tags (ESTs),
derived from different tissues or cell lines. Available data
enable large-scale computational analysis of AS in human
and mouse, and a few other organisms, with an average of
5 >200transcriptsavailableforeachannotatedhumangene(24).
Transcript-based AS databases include: the Alternative
Splicing Database Project, ASAP (25), the Alternative
Splicing Database, ASD (26), the Extended Alternatively
Spliced EST Database, EASED (27), SPLICEINFO (28)
10 and ECGENE (29), to name a few (18,30) (http://
hollywood.mit.edu/db/). Bioinformatics studies relying on
such databases have proven useful in revealing differences
in AS patterns between tissues (31–33), in identifying con-
served AS events in orthologous genes (34–38), and for
15 describing disease-associated AS (39). However, the AS
events recorded differ signiﬁcantly between different data-
bases, owing to differences in primary sequence data used,
in the algorithms used to generate spliced alignments, and in
the stringency of alignment quality ﬁltering.
20 More recently, splicing-sensitive microarrays have been
designed and used for the detailed analysis of tissue-
speciﬁc and other types of AS (40–45), and a cross-linking/
immunoprecipitation strategy has been introduced for the sys-
tematic identiﬁcation of RNAs bound by a given splicing
25 factor (46). These newly developed methods set a direction
toward increasingly parallel experimental analysis of splicing
regulation,and ASdatabaseswillbecome increasinglyimport-
ant in both experimental design and data analysis for these
types of functional genomic approaches.
30 To aid in computational and large-scale experimental stud-
ies of AS,we developedHOLLYWOOD,a comparativerelational
database of AS. HOLLYWOOD integrates accurate exon and
splice site annotation derived from spliced alignments of tran-
scripts to genomic sequences with current knowledge about
35 splicing regulatory elements and predicted AS events, and
links information about the splicing of orthologous genes in
different species to facilitate comparative analyses. A compact
representation of the splicing pattern of any desired gene is
provided, and sets of alternative or constitutive exons can be
40 obtained using complex queries for features such as splice site
strength, type of AS event, tissue expression, splicing regu-
latory element content or conservation of the AS event
between human and mouse.
HOLLYWOOD DATABASE
45 The design and implementation of HOLLYWOOD followed cer-
tain guiding principles: (i) all exon and isoform data should
derive from high-quality spliced alignment of transcripts to
genome sequences; (ii) AS events should be identiﬁed without
requiring designation of an arbitrary ‘reference’ transcript;
50 (iii) current knowledge about splice sites, splicing regulatory
elements and predicted AS events should be incorporated into
the database to allow efﬁcient searches; (iv) the database
should be integrated with other widely-used databases and
genome browsers when possible; and (v) two main types of
55 queries should be supported—queries for splicing information
about a particular gene or genes and queries for sets of exons
with particular properties. Examples of the output format for
each of these types of queries are shown in Figure 1A for
a gene query for the human fragile X mental retardation
60 syndrome-related (FXR1) gene, and in Figure 1B for an
exon query yielding exon 16 of the FXR1 gene.
HOLLYWOOD incorporates current knowledge about splice
sites and splicing regulatory elements. It uses both a standard
position-speciﬁc weight matrix model as well as a sophistic-
65 ated maximum entropy-based model for the quantiﬁcation of
30 and 50 splice site (30ss and 50ss) strength; the latter has been
shown to more accurately distinguish authentic and pseudo
splice sites (47,48). Inadditionto classical 30ssand 50ss motifs,
it is now well established that other cis-regulatory elements
70 including exonic splicing enhancers (ESEs) and silencers
(ESSs) play common and important roles in exon and
splice site choice (49). HOLLYWOOD annotates exons with
sets of candidate ESE and ESS elements that have been
identiﬁed in recent computational and experimental screens
75 (50,51). The database also incorporates information about
‘alternative-conserved exons’ (ACEs)—orthologous exon
pairs whose alternative splicing is conserved between
human and mouse—from two sources:  450 exons with
transcript evidence of AS in both species are annotated, as
80 well as  2000 candidate ACEs predicted by the ACESCAN
algorithm (35).
Primary data
In building the HOLLYWOOD system, ﬁve major data sources
were used, all of which are publicly available: (i) Ensembl
85 gene chromosomal locations and gene identiﬁers (52), corres-
ponding to genome assemblies from GoldenPath version hg16
of the human and version mm3 of the mouse genome (http://
genome.ucsc.edu); (ii) transcript sequences from GenBank
release 139.0, including the repositories gbpri, gbrod and
90 gbhtc; (iii) EST sequences from dbEST, release 01122004,
totaling  5.4 million human and  4.5 million mouse ESTs
[dbEST records were grouped into one of about 40 human or
mouse primary tissue types according to their cDNA library
information, as described previously (32)]; (iv) mammalian
95 interspersed repeat sequences from the RepBase repository
(53); and (v) sets of ESEs and ESSs from the RESCUE-
ESE and FAS-hex2 datasets, respectively (50,51).
Exon and feature annotation
Genomic sequences were extracted spanning an Ensembl gene
100 from the start to the end of the annotation, plus an addi-
tional 5000 nt upstream and downstream of the start and
end, respectively; these sequences are referred to as gene
‘slices’. The set of slices for all Ensembl genes was obtained
from EnsMart (54). Use of the Ensembl gene annotation to
105 deﬁne gene slices enables use of standard gene names and
identiﬁers and enables linking to external databases. However,
beyond the deﬁnition of slice boundaries, Ensembl annotation
is not explicitly used in HOLLYWOOD: all exon/intron annota-
tion and splicing information derives directly from transcript
110 alignments. For convenience, HOLLYWOOD generally uses
gene slice-based coordinates, which are converted to global
chromosomal coordinates as needed.
Large-scale spliced alignments of transcript sequences to
genomic DNA are conducted using the genome annotation
115 systemGENOA(http://genes.mit.edu/genoa),whichwillbedes-
cribed in greater detail elsewhere. Brieﬂy, GENOA detects stat-
istically signiﬁcant blocks of identity between repeat-ﬁltered
Nucleic Acids Research, 2006, Vol. 34, Database issue D57cDNA sequences and gene slices, then conducts spliced align-
ments of best-matched cDNAs to corresponding gene loci
using the algorithm MRNAVSGEN. To avoid problems attend-
ant to automated annotation of genomic regions, which are
5 subject to frequent rearrangement such as immunoglobulin
loci, cDNAs from certain classes of immune-related genes
are optionally excluded by GENOA. Statistically signiﬁcant
matches are then identiﬁed between EST sequences
and aligned repeat-ﬁltered cDNAs, and best-matched ESTs
10 are aligned to the corresponding gene slices using the SIM4
algorithm (55). GENOA was applied with stringent alignment
criteria, requiring a sequence identity above 93% for cDNA
A
B
D58 Nucleic Acids Research, 2006, Vol. 34, Database issuealignments. For ESTs, the ﬁrst and last aligned segments were
required to be at least 30 nt long, with a sequence identity of at
least 90%, and the entire alignment was required to have a
sequence identity of at least 90%, over at least 90% of EST
5 nucleotides. Using  22200 human and 25000 mouse gene
slices, these alignments criteria were passed by  79000 out of
115000 human cDNAs for  19300 gene slices, and by
roughly one-ﬁfth out of 5.4 million human ESTs, highlighting
the stringency of the applied quality ﬁlter. The same alignment
10 criteria were passed by only  27000 out of 102000 mouse
cDNAs for  13500 gene slices, while roughly one-ﬁfth out
of 4.1 million mouse ESTs met these criteria. GENOA aligned
2–4% of ESTs and  1% of cDNAs to multiple loci on
different chromosomes.
15 The annotation of exons as constitutive or alternative is
made by the program runHOLLYWOOD, which implements a
set ofcomputational rulestoidentify splice typesofalternative
exons (to be described elsewhere). HOLLYWOOD annotates
constitutive exons, skipped exons, mutually exclusive exons,
20 alternative 30ss and/or 50ss exons and retained introns.
By default, every exon is labeled as ‘constitutive’ and this
label remains unless speciﬁc criteria are met for annotation
as another alternative. Figure 2 shows for the human and
mouse genome the numbers of annotated constitutive and
25 alternative exons, together with a pictorial representation of
the criteria required for identifying each of these alternative
exon types. This annotation is not restricted to one splice type
per exon, but allows for exons to be included in multiple
categories, e.g. an exon may exhibit both skipping and
30 alternative 50ss usage.
Data model andimplementation as arelationaldatabase
The HOLLYWOOD system consists of a generalized alignment
parser framework, a relational database and a web interface.
HOLLYWOOD deﬁnes a relational data model that distinguishes
35 three primary tables—‘exon’, ‘gene’ and ‘transcript’—such
that updated or new information can be represented in a
structure consistent with existing data. A generalized parsing
module simpliﬁes the process of incorporating information,
which is provided in ﬂat ﬁle format. The parser currently
40 inserts data into the PostgreSQL relational database manage-
ment system, but could in principle support various database
back ends. The structured query language (SQL) provides
the ability to perform a wide range of powerful queries.
HOLLYWOOD can also be queried through a web interface
45 (Figure 3), with which users can build queries without
knowledge of SQL. This interface allows users to retrieve
sets of exons or transcripts that satisfy constraints deﬁned
on any number of supported features. Data are output in
ﬂat ﬁle or XML-based formats for downstream bioinformatic
50 analysis.
A primary design goal was to ease the process of importing
new data, and to this end HOLLYWOOD utilizes Perl packages
that hide database implementation details. The parser interacts
with the relational database backend, and the data model is
55 optimized for efﬁcient storage and data retrieval. Proper
normalization techniques are employed in HOLLYWOOD,
which facilitate the removal of redundant information and
contribute to the logical organization of the data model, and
the primary exon, gene and transcript data were decoupled
60 in order to minimize the number of tables that have to be
reloaded when a single input ﬁle is updated. For instance,
for an update of gene names/descriptions one only needs to
reload the corresponding table, and without further depend-
encies, the rest of the database remains unaffected.
65 HOLLYWOOD web interface and example applications
The HOLLYWOOD system is accessible at http://hollywood.mit.
edu. Human and mouse gene slices, comprising roughly one-
third of the human or mouse genome, are available for down-
load and organized by chromosomes. Gene locus-based (local)
70 coordinates are provided in 50–30 direction corresponding
to the transcriptional orientation of the gene in each slice;
corresponding chromosome-based (global) coordinates are
also provided.
Retrieval of exon sequences and features
75 A feature-selection form allows the user of HOLLYWOOD to
extract sets ofconstitutive and/or alternative exons, either for a
single gene, speciﬁed by its Ensembl gene identiﬁer or name,
or for genes that share similar descriptions (e.g. kinases).
The user can select exon features such as internal, constitutive
80 or alternative (e.g. skipped), inclusion in transcripts derived
from a particular tissue, conservation or presence of a
particular ESE hexamer (e.g. GAAGAA). After the user
has selected the features and submitted the form, exon
records that meet the criteria are retrieved from the
85 database. Figure 1A shows the data structure of such a
record for exon E16 of the FXR1 gene, which undergoes
tissue-speciﬁc AS (32,56).
As an example, a query with feature selection ‘hnRNP’ for
gene description, ‘Skipped exon’ for splice type, and ‘Internal’
90 for exon position retrieved  40 human exons, including
skipped exons in genes encoding hnRNP A1, hnRNP C and
hnRNP R. A second query for exons with features ‘Internal’,
‘Skippedexon’,‘Testis’fortissuetypeand‘TTCCTT’forESS
Figure 1. (A)ScreenshotoftheHOLLYWOODgraphicalinterfacesummarizingsplicingpatternsforasinglegene.Thetopoftheinterfacesummarizesspecies,locus,
Ensembl-linked gene number and name, gene description, and EST-derived tissue types with corresponding number of occurrences. The annotation performed by
HOLLYWOOD is complemented by ACESCAN-predicted splice-conservation and exons that were annotated by Ensembl. Color-coded boxes are used to link display
features with explanatory information. For each alternative exon splice type, HOLLYWOOD displays GenBank-linked accession numbers and primary transcript
structures of representative pairs of transcripts, which can be used to identify the alternative exons, and layers each structure onto the UCSC Genome Browser.
(B)H OLLYWOOD exon record for skipped exon E16 identified in the human fragile X mental retardation syndrome-related (FXR1) gene. FXR1 is an autosomal
homolog of the FXR gene and encodes an RNA-binding protein. Figure 1 shows data for exon E16, by searching HOLLYWOOD with ‘FXR1’ for gene name and
‘Skipping’ for exon type, with a schematic representation of features at top and the standard text output below. FXR1 is shown with two isoforms that alternatively
skip/include E16. Skipping of E16 results in a shift of the reading-frame that is predicted to alter and shorten the C-terminus of the FXR1 protein. E16 is an
ACESCAN[+]exonwithascoreof 0.2,andhencetheorthologousexonofthemouseFXR1ispredictedtoundergoexonskipping.Thisexonisperfectlyconservedin
sequence and contains two clusters of RESCUE-ESE hexamers. Transcripts aligned to the locus of FXR1 show E16 included in more than a dozen transcripts (two
cDNAs AY341428 and HSU25165, and >10 ESTs) and excluded in  30 other transcripts (cDNA BC028983 and other ESTs), and ESTs suggest that FXR1 is
expressed in many tissues.
Nucleic Acids Research, 2006, Vol. 34, Database issue D59sequence element retrieved  160 skipped human exons,
which included the sperm-speciﬁc thioredoxin 2 (Sptrx) gene
and the gene encoding the spermatogenesis cell apoptosis-
related protein 1. A third query for exons with features
5 ‘Internal’, ‘Constitutive exon’ and positive ACESCAN scores
(orthologous exon pairs predicted to be alternatively spliced in
both human and mouse). The HOLLYWOOD system retrieved
 1400 ACEs, including exon 5 of the tissue-speciﬁc RNA-
binding protein NOVA-1, which has recently been identiﬁed
10 as a skipped exon that is auto-regulated by NOVA-1 (57). As a
ﬁnal example, HOLLYWOOD was queried ﬁrst with the feature
selection ‘Skipped exon’ for splice type, ‘Brain’ and ‘GAA-
GAA’ for ESE sequence element, and was then queried with
‘GGTAAG’ for ESS sequence element, keeping the remaining
15 features as selected previously. It retrieved  470 exon records
for the ﬁrst query, and  50 exon records for the latter query.
These examples anticipate some of the types of analysis of
alternative exons and functional sequence elements that can
be conducted using HOLLYWOOD.
20 Viewing AS patterns
In addition to speciﬁc sets of exons, queried for by employing
the feature selection form, HOLLYWOOD allows the user to
display a summary of the splicing information contained in
the database for one gene at a time.The user simply queries for
Figure 3. Web interface offering two feature-selection forms for searches for sets of exons with specific splicing characteristics or splicing regulatory element
composition(left),orforthesplicingpictureforaspecificgene(right).Eachfeatureislinkedtotheonlinedocumentationwithexplanatoryinformationaboutfeature
utilization,valuesornomenclature.Ensemblgeneidentifiersaremostreliableforquerying,asgenenamesareoftennotstandardized,andresponsetimeistypically
within seconds, depending on the complexity of the query.
Figure 2. Tree representation of numbers of human (left) and mouse (right) alternative and constitutive exons in HOLLYWOOD. All exons are supported by spliced
alignments of transcript sequences with minimal acceptor and donor splice sites AG/ and /GT or /GC, respectively. Splice sites required to identify constitutive
and alternative exons are marked bolded in black. HOLLYWOOD branches its annotation as follows: (i) on the first level, it distinguishes between first, internal and
last exons; (ii) on the next level, it distinguishes between constitutive exons, with constant 30ss and 50ss, and alternative exons, with varying 30 and/or 50ss; (iii)
on the last level, alternative exons are annotated as skipped, alternative 30ss, alternative 50ss, overlapping, or mutually exclusive exons. In addition, introns
that are retained in mature mRNA are annotated as intron retention events. Alternative exons may undergo multiple splice variations and can belong to multiple
branches.
D60 Nucleic Acids Research, 2006, Vol. 34, Database issuea speciﬁc gene by name or by Ensembl identiﬁer, and selects
the display option. Alternatively, one may obtain a sequence-
based representation of the display, and download all tran-
scripts mapped to the gene locus.
5 After a gene is selected, a diagram illustrating splicing
patternsiscomputedinreal-timeand displayed. Suchadisplay
for the human FXR1 gene is shown in Figure 1A, supported by
legends. The HOLLYWOOD annotation is presented as a set of
evaluated reference exons, each of unit size and color-coded as
10 ﬁrst,internalorlastexon,withinternalexons furtherannotated
according to their splicing properties as constitutive or altern-
ative. The HOLLYWOOD annotation shown derives from exons
supported by spliced alignments with minimal consensus 30ss
and 50ss sequences (AG/ and /GT or /GC, respectively). For
15 clarity, the ﬁrst and last segments of EST alignments (which
generally correspond to incomplete portions of exons) are not
displayed. Similarly, ﬁrst and last exons are clustered and
represented asﬁrst/last‘exon regions’ tosimplifythe diagrams
and focus attention on splicing-related (rather than transcrip-
20 tion- or polyadenylation-related) information. HOLLYWOOD
does not display all obtained spliced alignments (which
often number in the hundreds or more), but provides a
streamlined representation, displaying pairs of ‘representative
transcripts’, which support the inference of each AS event.
25 Finally, the HOLLYWOOD display can conveniently be
layered onto the UCSC Genome Browser, by using custom
tracks that are provided as links on the display, for detailed
comparisons with other existing annotations and inspection of
multi-species sequence conservation.
30 HOLLYWOOD MAINTENANCE AND DEVELOPMENT
The ﬁrst-phase development of HOLLYWOOD has matured
such that the public release 1.0 can serve as a central resource
for data and graphical display of patterns of alternative
pre-mRNA splicing. Updates, improvements and further
35 developments will be ongoing, and are currently envisioned
asextensionsforcomparative genomics,perhapswith layering
onto the Ensembl Genome Browser, integration of external
annotations and incorporation of splicing-speciﬁc microarray
data with links to exon records.
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